This transcriptional inhibition is relieved, on the one hand, by Sirtuin 1 (SIRT1), an NAD-dependent deacetylase that induces XPC expression by preventing nuclear localization of the E2F4-p130 repressor [94]. The gene discussed is SIRT1; the disease is Xeroderma pigmentosum complementation group C.